• Lexaria’s Patented DehydraTECH technology improves the bioavailability of pharmaceuticals and therapeutics for a number of developing applications
• Lexaria is set to complete its DEM-A22-1 and DIAB-A22-1 studies on dementia and diabetes, respectively, in January 2023, with analysis and reporting set to follow soon after
• These studies will build on the just-concluded hypertension clinical study whose results were “truly exceptional,” demonstrating a statistically significant lowering of blood pressure in the patient population over multiple weeks
• There is an established link between hypertension and vascular dementia, along with hypertension being twice as frequent in people with diabetes and hypertensive patients being at greater risk of developing diabetes
• The success of these two studies will draw Lexaria closer to tapping into the dementia drug market, which is projected to hit $32.3 billion by 2030, and the diabetes drug market, which is expected to reach $82.92 billion by 2027

Lexaria Bioscience (NASDAQ: LEXX) just announced two notable studies, DEM-A22-1, and DIAB-A22-1, on dementia and diabetes, respectively, scheduled for completion in January 2023. The studies seek a deeper understanding of the company’s patented DehydraTECH(TM)-processed CBD for its potential therapeutic utility against both conditions (https://ibn.fm/Uta3i). According to John Docherty, Lexaria’s President and Head of Research, these studies will build on the just-concluded hypertension clinical study whose results he referred to as “truly exceptional.”  The study demonstrated a statistically significant lowering of blood pressure in the patient population over multiple weeks, something that, Docherty noted, other entities using other oral CBD formulations have failed to replicate or even evidence. “The study demonstrated excellent safety and tolerability of DehydraTECH-CBD and no adverse changes in liver enzymes throughout the study, a common concern in CBD dosing. We were also able to show that decreases in blood pressure were similar in participants currently taking standard of care hypertension medications to those not undergoing any concurrent blood pressure treatment,” he noted. There is an established link between hypertension and vascular dementia. In addition, hypertension is twice as frequent in people with diabetes, and hypertensive patients are at greater risk of developing diabetes. Lexaria looks to draw from the success of its hypertension clinical study to show DehydraTECH-CBD’s potential to offer potential therapeutic utility against these two conditions. Currently, dementia is ranked as the seventh leading cause of death among all diseases, accounting for 40 out of every 100,000 deaths in the United States (https://ibn.fm/V8TiC). It also currently affects seven million Americans and has a significant unmet need that Lexaria hopes to meet. Diabetes, on the other hand, ranks as the eighth leading cause of death in the United States, accounting for 31 out of every 100,000 deaths in the country (https://ibn.fm/ACcAT). Over 37.3 million people, representing 11.3% of the country’s population, live with the condition, yet few viable treatment options are available for them (https://ibn.fm/3O03G). CBD has, so far, shown some ability to reduce the incidence of diabetes in mice due to its powerful anti-inflammatory and antioxidant properties. In addition, Lexaria has proven DehydraTECH’s ability to cross the blood-brain barrier effectively. As such, it is optimistic that it will achieve potential treatment for both dementia and diabetes. “We are excited to investigate whether DehydraTECH-CBD has a potential application in the treatment of dementia and diabetes based on its propensity to cross the blood-brain barrier, the fact that DehydraTECH-CBD lowers human blood pressure, and the fact that CBD is known to have vasodilatory, anti-inflammatory and antioxidant effects,” noted Mr. Docherty. The two studies will be undertaken by leading third-party testing laboratories in Canada, with analysis and reporting set to follow their scheduled completion in January 2023. Their success will draw Lexaria closer to tapping into the dementia drug market, projected to hit $32.3 billion by 2030, and the diabetes drug market, which is expected to reach $82.92 billion by 2027. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• The Inflation Reduction Act (“IRA”), a linchpin to the U.S. meeting its emissions goals, includes $369 billion dedicated to expanding renewable energy
• The new bill is projected to generate $600 billion in capital investment, 550,000 clean energy jobs, and 525-550 gigawatts of new clean power
• The passage of the IRA served as a catalyst to solar stocks and continues to grow interest in upstarts like GeoSolar Technologies

President Joe Biden is on a mission to cement his legacy as an ambassador of all things anti-climate change. The passage of the Inflation Reduction Act will forever be his key piece of legislation as he doubled down on America meeting its emissions targets. The administration’s efforts are good for solar stocks from up-and-comers like GeoSolar Technologies (“GST”) to established brands like First Solar (NASDAQ: FSLR) and the loyal solar investment community that has endured over the last decade as solar builds momentum.

“We’re proving that good climate policy is good economic policy,” said President Biden in a speech at the COP27 climate negotiations in Egypt. Biden emphasized, “The United States of America will meet our emissions targets by 2030.” The country has a promised to cut greenhouse gas emissions by at least half compared to 2005 levels by the end of this decade, which means an acceleration in efforts considering the current trajectory has the U.S. reducing emissions by just under 40 percent by 2030.

The U.S. is the second biggest emitter of greenhouse gases in the world, trailing only China. The recently passed Inflation Reduction Act (“IRA”) earmarks $369 billion to expand renewable energy over the next 10 years, the nation’s biggest commitment ever to alternative energies like wind, solar, and electric vehicles. Notably, the IRA adds tailwinds in American trends to reduce dependence on China for alternative energy products. Tariffs on Canadian products have been lifted and incentives abound encouraging companies and consumers to shift away from fossil fuels.

The American Clean Power Association estimates that the IRA will generate $600 billion in capital investment, while creating 550,000 clean energy jobs and 525-550 gigawatts of new clean power.

Investors piled into depressed alternative energy stocks as it became increasingly clear that the IRA was going to be passed. This was evident in money rotation in exchange trading funds (“ETFs”) flipping from net outflows of $223 million in the two weeks prior to news of a Congressional agreement on the IRA July 27 to $433 million of net inflows, according to Morningstar data.

Subsequent to the lawmakers’ pact in July ahead of the IRA bill becoming law, individual solar stocks have performed well. First Solar shot from $70 in July to $161 in November. Enphase (NASDAQ: ENPH) is up approximately 85%, SunPower (NASDAQ: SPWR) has gained 37%, and Array Technologies (NASDAQ: ARRY) has surged 67%, amongst others.

Rising interest rates have not had much of a negative impact on solar stocks either. Now, with the Democrats keeping control of the Senate, the cheers for solar could get louder. Against this backdrop, GeoSolar Technologies eyes a public listing. Denver-based GeoSolar is the creator of the SmartGreen(TM) Home system (all-electric) that harnesses the power of the earth and sun to let people own their own green energy system and disconnect from the utility grid.

The company was founded in 2020 by an elite team of respected climate scientists for the purpose of making a meaningful impact on climate change. In that effort, the team developed an all-house solution featuring solar and geothermal technologies that is suitable for warm and cold climates, new construction, renovations, and retrofits.

A SmartGreen(TM) home is the epitome of efficiency. GeoSolar ensures the envelope (the exterior walls and attic are properly insulated to keep the outside temperature out and inside temperature consistent. The system involves using all electric appliances and mechanicals (no propane or natural gas allowed) because the heart of a SmartGreen(TM) home is on the roof in the form of a photovoltaic solar panel system. The solar panels provide all the electricity the home requires, including optional electric vehicle charging stations also provided and installed by GeoSolar.

Heating and cooling utilize geothermal, which involve installing underground piping, called ground loops. Ground loops are run at a depth where temperatures are consistent year-round. In this capacity, the earth serves as a heat source or heat sink, depending on if heating or cooling is required, as a critical part of an electric geothermal heat pump system.

GeoSolar’s SmartGreen(TM) homes also feature a CERV® Air Filtration systems that provide ultra-clean air free of pollutants and pathogens, including SARS-CoV-2, the coronavirus responsible for COVID-19. GeoSolar handles the complete process from design through construction and even assists with 100% financing options and any tax deductions and government incentives available.

The whole patent-pending process to flip to all natural energy resources can be completed in a few weeks. The first SmartGreen(TM) homes have been constructed in GeoSolar’s home state that is known to have hot summers and snowy winters where they have received some of the highest scores in the industry standard Home Efficiency Rating System (“HERS”).

As it raises money via a Regulation A+ capital offering and readies to join the public domain, GeoSolar has the fundamentals in place to expand its geographical footprint that includes some 84 million outdated homes with obsolete, pollutive, fossil fuel-powered energy systems and 1.4 million new homes constructed each year.

For more information, visit the company’s website at www.GeoSolarPlus.com.

NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• Corporations worldwide are working to improve their climate friendliness through a variety of environmental, social and governance (“ESG”) factors
• U.S. distributed energy solutions innovator Correlate Infrastructure Partners Inc. is a company working strategically with clients to assess their energy emissions profile and identify possible improvements and funding opportunities for those improvements
• CIPI’s advisement helps clients achieve transparency in their ESG responsibility and to make improvements in a cost-beneficial manner
• CIPI has realized record revenues during the most recent quarter as a result of its operations and still has $16.2 million in unrecognized revenues anticipated from work currently under way

Environmental, social and governance (“ESG”) responsibility has come to define corporate attention to climate change and steady drive toward clean energy adoption. While nearly a decade has passed since some 200 international entities and their governments forged a compact for reducing fossil fuel dependence and analysts expect several more to pass before meaningful progress becomes apparent, improvements are under way (https://ibn.fm/Jt8QL).

One entity helping to advance progress on the greenhouse gas reduction front is a tech-enabled development, finance, and fulfillment platform from Correlate Infrastructure Partners (OTCQB: CIPI). The company is making it easier and cost effective for those in the commercial real estate industry to acquire the necessary solutions for solar, cogeneration, energy storage, and electric vehicle infrastructure, as well as driving intelligent efficiency retrofits for community-scale applications.

The key for companies to open the door to ESG success is to first evaluate their current energy use and emissions profile and identify key stakeholders who will be vital to advancing any strategy toward new targets. Correlate Infrastructure provides proprietary analytics and advisement for companies seeking to reduce the carbon footprint of their buildings before helping clients navigate the tricky journey toward managing and financing infrastructure improvements for a better and more affordable ESG outcome.

“Correlate Infrastructure Partners is making energy management and procurement transparent and cost-effective as we digitize the process that has been archaic for way too long,” CEO Todd Michaels stated earlier this year (https://ibn.fm/Rsdg7). “We are excited to be at the forefront of an industry that is at an inflection point, and we are eager to begin working to change the way commercial real estate owners optimize energy assets.”

To be effective in reducing their carbon emissions, companies need to consider not only the facilities they control directly, but also the impact of the utilities they purchase and other indirect expressions of their energy use profile upstream and downstream from their operations.

Once the elements of a reduced-emissions profile are identified and a strategy established, companies can begin working toward acquisition of necessary resources for on-site renewables or power purchase agreements as appropriate, reporting progress according to company standards and communicating that progress to the public.

Correlate’s ability to provide clients with distributed energy solutions that come with smart cost-reduction incentives and associated financing has led to record revenues for the most recently reported quarter. In addition, the company has another $16.2 million in unrecognized revenues anticipated from work that is currently under way. Overall, the company foresees project opportunities valued at up to $194 million.

For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

RHK Capital is organizing the RHK Capital 2022 Disruptive Growth Conference, at the offices of Reed Smith, NYC. Spread over two days on December 5-6, 2022, investors, brokers, wealth managers, capitalists, growth companies and enterprises, are invited to attend this interactive learning and network-building conference in person or via webcast. The focus of RHK Capital in this in person and webcast conference is to spotlight aspiring companies and young industries with disruptive growth potential.

The RHK Capital 2022 Disruptive Growth Conference is attended by over 200 institutional investors, accredited investors, family offices, Wall Street analysts, financial advisors, broker-dealer wealth managers, and RHK clients. Up to 30 senior company executives pitch their business ideas and host engaging presentations in front of industry leaders and investors.

The RHK 2022 conferences are well-researched events that showcase the best talent in areas of communications, consumer, healthcare, energy or alternative energy, natural resources, life sciences, and technology. They bring deserving companies to the forefront of the most influential and important investors in their spectrum. On the other end, RHK Capital Conferences offer investors new investment avenues and innovative ideas.

This is an important forum for investors to discover and do business with disruptive growth companies. As RHK Capital Conferences are well-curated events, the team understands the requirements of the companies and interested investors. They guide and direct activities to encourage creative communication and connections.

The conference days will feature panel discussions, one-to-one sessions, and interactive networking among the companies. Young enterprises can meet and connect with other participants to discuss the specific challenges and opportunities in their niche areas.

As emerging growth companies pave the way for novel ideas and innovation, investors can leverage this opportunity and provide support to help them reach their full potential more quickly, profiting as early participants. Along with the learning sessions at this conference, enterprises, growth companies, and investors can collaborate and grow together in these quickly changing times.

To learn more, please visit https://ibn.fm/eAtz4.

Become a part of the 2023 U.S. debut of Lift Events & Experiences, at the Moscone Center in San Francisco, from Wednesday, August 2 – Friday, August 4, 2023. The leader in Canada, Lift’s first conference over the border offers exclusive content, robust networking, and unparalleled new product discovery opportunities. The event is dedicated to the evolution of the cannabis industry, and brings to the U.S. Lift’s long-established and respected reputation for powerful cannabis events.

After proving its mettle in Vancouver and Toronto, the former Lift&Co. Expo will now simply be called ‘Lift’, reflecting its expanding footprint. Lift invites attendees for unique and immersive learning experiences in 2023, including Lift Vancuover (January 12-14, 2023), Lift Toronto (June 1-3, 2023) and at the new Lift San Francisco event (August 2-4, 2023). With Lift now expanding its coverage to the U.S., the ties between the U.S. West Coast and Western Canada’s long-thriving cannabis culture are expected to strengthen further.

“Lift welcomes everyone, from legacy participants to multistate operators to everyday folks who enjoy and respect the plant,” says Lift Events & Experiences Portfolio Lead, Lindsay Roberts. “We’re producing a year of shows that care for the specific needs of each segment of the cannabis community while inspiring an exciting future. To emphasize this commitment, we’re dropping our old ‘&Co. Expo’ moniker to put the focus simply on ‘Lift’ as we work to affect positive change across North America.”

Lift events are attended by cannabis industry veterans and fresh voices alike, always presenting valuable and updated information through speaker sessions and presentations on topics vital to the cannabis business and trade. Connect with cannabis experts, innovators, regulators, and leaders of the cannabis business community, build long-term business ties, and get discovered by potential investors on this robust networking forum.

Through one-on-one interactions and communication, the Lift team ensures that every company or individual attending the event is presented with an abundance of opportunities, including growers, brands and product delivery, advocacy and investment, legal/compliance, retailers, budtenders, enthusiasts and more.

For more information on Lift Events & Experiences, visit https://liftevents.com/.

• CubCrafters’ announcement about filing for Reg A qualification with the SEC was met with enthusiasm as investors pledged $5 million in reservations for 1 million planned shared in the first 48 hours following the announcement
• The company intends to use some of the infusion of funding to accelerate production rates as they are sold out through late-2024and anticipate taking orders for 2025 soon
• The backcountry aircraft market is expected to reach $11.9 billion by 2030
• CubCrafters company focuses on four main product lines – the Carbon Cub FX, NXCub, XCub, and Carbon Cub EX kits, and announced a new engine option in August 2022

The light and ultralight aircraft market is projected to grow from $7.5 billion in 2022 to $11.9 billion in 2030, driven by the number of backcountry enthusiasts growing on the heels of the COVID-19 pandemic (https://ibn.fm/xH1g2). “Light aircraft” is classified as any aircraft with a maximum gross takeoff weight of 12,500 pounds or less and are most commonly used for general aviation purposes. Best-in-class backcountry aircraft producer CubCrafters is leveraging the anticipated industry growth after announcing its intentions of a public offering under Reg A qualifications with the U.S. Securities and Exchange Commission (“SEC”).

Within the first 48 hours of the company’s announcement, CubCrafters was met with enthusiastic investor interest, with $5 million in reservations for 1 million planned shares, growing to over $25 million in reservations and is on track to reach its planned $50 million target as it awaits qualification for its listing with the SEC.

CubCrafters was founded in 1980 by Jim Richmond after a thorough fact-finding mission in Alaska, resulting in selling his home insulation business and switching to rebuilding Super Cubs. The company is driven by Jim’s vision and the ability to optimize performance potential of the Super Cub legacy. CubCrafters introduced its first new aircraft in 1999, the Piper/CubCrafters PA18, built under the FAA’s Spare & Surplus Rule.

The company focuses on four main product lines – the Carbon Cub FX, NXCub, XCub, and Carbon Cub EX kits. The models are built to be lightweight and powerful, with some emphasizing short take-off and landing capabilities, and others built for longer missions in unforgiving backcountry environments. Dominating this sector, the company has developed seven models that emphasize flexibility, including varied landing gear configurations such as nosewheel, tailwheel, floats, and skis.

In the Reg A announcement, Vice President of Sales and Marketing Brad Damm discussed how CubCrafters plans to use an infusion of funding to accelerate the production rate, making special note that the company has already sold out through late-2024 and is expecting to begin taking orders for 2025. (Source)

In August, the company debuted a new lightweight engine for its Carbon Cub model, improving the CC340 that made previously unheard-of short takeoff and landing performance possible for backcountry enthusiasts. The new CC363i F/P is a higher displacement fuel-injected engine with more horsepower than the CC340, according to CubCrafters. As the flight test program is nearing completion, new engines will begin shipping to customers, with priority given to those wishing to upgrade their existing kit aircraft order.

“This is an engine our customers have been specifically asking for, especially our kit aircraft customers. It’s simple to operate and has better overall performance than any of the other fixed-pitch engines we offer,” said Damm, who flew the first CC363i F/P equipped Carbon Cub (https://ibn.fm/Qmih4). “It’s smoother, more fuel efficient, and it cools better. Customers who choose this new engine are going to be pleased for sure.”

For more information, visit the company’s website at www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

• California retail stores sold almost $5.3 billion worth of cannabis products in 2021 and reported a total tax revenue of approximately $1.3 billion
• California’s three licensing authorities issued 12,227 commercial cannabis licenses to businesses throughout the state during 2021
• San Diego has approved a social-equity program, joining the ranks of other California cities and counties that have implemented them since 2018, utilizing tax revenues from the cannabis industry
• REZYFi is the first cannabis mortgage company in the United States – a market where most traditional lenders are still reticent to enter

On November 8, 2016, California voters approved cannabis for recreational use. Since then, the market has continued to increase in revenue, and it is expected to make up 61.5% of the overall market, according to the University of California Agricultural Issues Center. In 2021, California retail stores sold almost $5.3 billion of cannabis products, indicating a 20% growth over 2020 and over 20% of legal sales in the United States. The total tax revenue reported by the cannabis industry was about $1,317.6 million in 2021, including approximately $680.4 million in excise tax.

As of December 2021, California’s three licensing authorities issued 12,227 commercial cannabis licenses to businesses throughout the state – including 8,504 cultivators, 915 manufacturers, 842 retailers, 362 delivery services, 1056 distributors, 308 microbusinesses, 152 transporters, 46 event organizers, 42 testing laboratories (https://ibn.fm/e6dbB).

The San Diego Union-Tribune reported that the San Diego City Council recently approved a social-equity program for the city’s cannabis industry, including start-up loans, fee waivers, and other business assistance. Although San Diego was the first California city to approve an adult-use cannabis licensing plan in 2017, the plan did not include social equity provisions.

The social-equity plan requires that applicants meet various criteria:

• Conviction of a cannabis-related crime or having a family member convicted of a cannabis crime after January 1, 1994, within the San Diego city limits; and be a current or former resident – for at least five cumulative years between 1980 and 2016 – including Barrio Logan, Linda Vista, southeastern San Diego, Encanto, Golden Hill, North Park, City Heights, the College Area, or San Ysidro.
• Applicants must also meet two additional criteria, including a household income below 80% of the area median income ($106,900 for a family of four); lost housing in San Diego through eviction, foreclosure, or subsidy cancellation after 1994; attended school in the San Diego Unified School District for at least five years between 1971 and 2016; or placed in the foster care system at any time between 1971 and 2016.

Since the state started allowing equity plans in 2018, Long Beach, Los Angeles, Oakland, Palm Springs, Sacramento, and San Francisco have launched such programs, including Humboldt, Lake, and Mendocino counties, which have programs funded by state cannabis taxes (https://ibn.fm/3X0ZK).

Despite the massive market growth recently, most traditional lenders are reticent to serve the state-licensed cannabis industry, but one company, REZYFi, is positioned as the first cannabis mortgage banker in the United States. REZYFi services the needs of both traditional and non-traditional consumers and businesses. The company is targeting markets that include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

REZYFi operates under two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. REZYFi Lending primarily addresses emerging real estate-related financing opportunities. ResMac is the Company’s traditional mortgage origination, correspondent, and servicing operation. As a whole, REZYFi is using its corporate strengths as a foundation for diversifying its approach to capitalize on growth in multiple verticals in the years to come.

For more information, visit the company’s website at www.REZYFi.com.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://ibn.fm/REZY

• Cyberattacks on SMBs have increased due to the changing network landscape due to the increase in remote and in-office workers relying on cloud environments, mobile devices, software applications, and third-party suppliers to conduct business
• SideChannel announced its preliminary revenue of $4.6 to $4.8 million for the fiscal year that ended September 30, 2022 – a 64% to 71% year-over-year increase from the company’s revenue of $2.8 million during the fiscal year 2021
• SideChannel continues to expand its service offerings, workforce, and customer base and has attracted over 20 vCISOs to serve across industries, including fintech, biotech, healthcare, manufacturing, legal defense, and technology services

Cybersecurity protects networks, information, and personal data from being vulnerable to cyberattacks. According to ReportLinker, the global cybersecurity market was valued at $150.37 billion in 2021 and is expected to reach a value of $312.02 billion by 2027, growing at a CAGR of 13.37%. The trends driving growth in this market include BYOD, AI, IoT, and machine learning; coupled with the significant reduction in device costs, increasing the number of connected network devices is driving the growth of the market. The emergence of 5G is also expected to expedite the use of connected devices in the industry, pushing toward industrial revolution 4.0 (https://ibn.fm/siJ6Y).

Reports have shown that cyberattacks on SMBs (small and mid-sized businesses) have increased due to the changing network landscape, with remote and in-office workers increasingly relying on cloud environments, mobile devices, software applications, and third-party suppliers to conduct business. For mid-market companies looking to increase their cybersecurity, SideChannel (OTCQB: SDCH) simplifies cybersecurity by matching these companies with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time chief information security officer (“CISO”).

SideChannel’s team of virtual CISOs (“vCISOs”) offers 400-plus years of combined experience in cybersecurity – honing their skills and abilities in corporations like Anthem, Dick’s Sporting Goods, BestBuy, TD Bank, and the Pentagon. SideChannel lends its talent to clients, creating value in its bespoke cybersecurity program, which is perfectly sized for the growing enterprise.

Prior to the company’s participation in the LD Micro Main Event XV at the end of October 2022, SideChannel announced that preliminary revenue reached $4.6 to $4.8 million for the fiscal year that ended September 30, 2022 – a 64% to 71% year-over-year increase from the company’s revenue of $2.8 million during the fiscal year 2021. SideChannel also announced securing six new clients with a combined annual revenue value of $1.3 million and signing renewal contracts with existing clients. The company expects to recognize the revenue associated with the new clients and signed renewals within 12 months of the signature date, along with the related incremental engineering, products, and services revenue.

“We are winning exciting new recurring revenue customer agreements with well-known middle-market names across diverse industries. For example, our wins include engagements with names such as Handshake, Veza, Kiava, Riot Blockchain, and Lightcast,” SideChannel CEO and Founder Brian Haugli said (https://ibn.fm/Yq7O0). “Additionally, we are typically generating substantial incremental revenue on the engineering and services associated with these agreements, further increasing the value of our new customer engagements even beyond the initial contracted services.”

SideChannel continues to expand its service offerings, workforce, and customer base and has attracted over 20 vCISOs to serve across industries, including fintech, biotech, healthcare, manufacturing, legal defense, and technology services. To date, the company has created more than 50 multi-layered cybersecurity programs for its clients – requiring it to expand its sales force from one position to five in 2022. This reflects the large and growing sales funnel of SMB customer opportunities for its vCISO and cybersecurity services. SideChannel is committed to creating the solutions necessary for SMBs to protect their data and assets in the ever-changing cybersecurity market landscape.

For more information, visit the company’s website at www.SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

• U.S.-based drug innovator CNS Pharmaceuticals is continuing to advance its global human clinical trial for Berubicin, a potentially pivotal treatment for the incurable brain cancer glioblastoma
• CNS recently announced its Q3 financial results, including an update on the clinical development that noted the start of patient enrollment and dosing in France
• CNS is also advancing trial sites in the United States, Switzerland, Spain, and Italy, with 29 of 68 anticipated sites currently enrolling patients
• The company expects to provide an interim analysis of the trials in mid-2023 and primary completion in 2024, with ultimate resolution in 2025
• The FDA has granted Berubicin Fast Track and Orphan Drug status, speeding the possibility of marketing the drug following the potentially pivotal clinical review

Innovative brain tumor therapy developer CNS Pharmaceuticals (NASDAQ: CNSP) is reporting continued expansion of the number of clinical site launches for its evaluation of the company’s lead product candidate for treating recurrent glioblastoma multiforme (“GBM”). CNS Pharmaceuticals noted in a recent update about its anti-cancer drug candidates and its third quarter financial results that the potentially pivotal trial for its lead candidate — Berubicin — has begun patient enrollment and dosing in France, bringing its operational tally to 29 of 68 clinical sites now enrolling patients across the United States and Europe. “This expansion into Europe drives us toward our goal of interim analysis, expected in mid-2023, which we believe has the potential to be (a) transformational milestone,” CEO John Climaco stated in a company news release providing the update (https://ibn.fm/ULeIw). “Moving forward, we are focused on building momentum and advancing this important program across the finish line.” GBM is an incurable brain cancer that is diagnosed in approximately 13,000 U.S. patients alone each year, and that number is expected to grow. Up to 50 percent of original malignant tumors of the central nervous system (“CNS”) are glioblastomas, and those patients have an average survival time of about a year after diagnosis — only 10 percent or less survive to five years (https://ibn.fm/b2Imf). “Unfortunately, there is a paucity of effective treatment options for glioblastoma, despite it being the most common primary brain tumor in adults,” an Oncology Nursing News report on radiation’s effects on overall survival (“OS”) states (https://ibn.fm/3p1pp). While radiation can significantly improve OS in newly diagnosed GBM patients, as the cancer recurs (which it generally does), reirradiation combined with a standard drug treatment improves progression-free survival (“PFS”) for a few months but not OS, the report states, citing findings published in the Journal of Clinical Oncology. The need to find an effective solution for surviving such a common brain cancer has created a competitive search for a better treatment. CNS Pharmaceuticals’ development of anti-cancer drug candidates is spurred by Berubicin’s performance in a safety trial conducted in 2006 by the drug’s initial developer, Reata. That initial small trial involved two dozen evaluated patients, one of whom has remained free of brain cancer during the intervening years. And nearly half of the trial’s other patients experienced a statistically significant improvement in clinical benefit (https://ibn.fm/a8hbj). CNS Pharmaceuticals’ expansion of clinical trials evaluating Berubicin included initial reports of its performance against cells in the lab and rose to the level of a global human trial comparing Berubicin responses to those of patients treated with Lomustine, another GBM standard of care. In addition to the United States and France, trial site initiations are being advanced in Italy, Spain and Switzerland. Berubicin has received Fast Track and Orphan Drug Designation from the U.S. Food and Drug Administration (“FDA”) to help speed its potential reviews and marketability as the trial is completed. For more information, visit the company’s website at www.CNSPharma.com. NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

• Renewable energy movement growing in construction sector, backed by solar panel and geothermal technology
• GeoSolar’s SmartGreen(TM) Home system offers a total-home makeover, including solar panels and geothermal ground loops
• Additional SmartGreen(TM) features include building envelope optimization, and upgrades to insulation, windows, and lighting systems
• SmartGreen(TM) can be adapted to new construction and existing buildings within weeks
• GeoSolar conducting Regulation A+ capital raise

Environmental degradation, energy price instability, and a declining economy paint a grim picture for many people across the world. Despite the negativity, a renewable energy movement is taking shape, backed by companies like GeoSolar Technologies (“GST”), a climate technology company based in Colorado. GeoSolar’s SmartGreen(TM) Home system offers multiple solutions to the planet’s growing challenges. The technology provides a total-home makeover that replaces fossil fuel-based energy systems with solar panels and geothermal ground loops to provide heating, air conditioning, and electricity to power appliances. Energy efficiency is also maximized in a SmartGreen(TM) home by tightening the building envelope and upgrading insulation, windows, and lighting systems. Backed by a successful track record across multiple test homes in Colorado, SmartGreen(TM) recently earned top scores on the Home Energy Rating System (“HERS”) Index – the industry’s gold standard for calculating energy performance and efficiency. Besides being more energy efficient, HERS-rated homes have a higher property value according to the North Carolina Building Performance Association (https://ibn.fm/vPsfo). Energy prices are rising across the world, leading to political instability. SmartGreen(TM) technology helps insulate owners from price shocks by drastically reducing or eliminating utility bills and providing energy independence. SmartGreen(TM) homes also offer an EV charging station entirely powered by photovoltaic solar panels, giving homeowners an additional way to transition away from fossil fuels. Renewable energy systems like SmartGreen(TM) may become more affordable for homeowners across the U.S. through the Inflation Reduction Act of 2022 (https://ibn.fm/KXrl6). Rebates offered by the legislation include new electrical panels and heat pumps, along with a 30% solar tax credit. In addition to subsidizing solar panels, the Department of Energy announced a program to reduce geothermal system costs by 90% to $45 per megawatt hour by 2035 (https://ibn.fm/xo1YD). GeoSolar aims to market SmartGreen(TM) to over 120 million homes across the U.S. with options to build the system into new construction or adapt it to existing buildings. As part of its strategy, the company recently gained approval from the US Securities and Exchange Commission to conduct a Regulation A+ capital raise that allows the public to participate with a minimum $300 investment. For more information on GeoSolar’s Regulation A+ capital raise, please visit https://www.manhattanstreetcapital.com/geosolar-technologies-inc. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST